FDA hopes to simplify and standardize Covid shots without making them interchangeable
The FDA’s advisory committee of outside vaccine experts will meet Thursday to discuss how to simplify the Covid-19 vaccination process, make the strain selection process easier and more regular, and decide whether to use the same strain for both the primary and booster doses.
But despite a desire by the agency to simplify the vaccination production and administration process, the agency acknowledged that, for now, it may be challenging to harmonize different vaccines from Moderna and Pfizer/BioNTech into a single, interchangeable shot.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.